
Medifast Inc
NYSE:MED

Medifast Inc
Common Stock
Medifast Inc
Common Stock Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Medifast Inc
NYSE:MED
|
Common Stock
$11k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
Estee Lauder Companies Inc
NYSE:EL
|
Common Stock
$6m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
![]() |
Bellring Brands Inc
NYSE:BRBR
|
Common Stock
$1.4m
|
CAGR 3-Years
52%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
![]() |
Coty Inc
NYSE:COTY
|
Common Stock
$9.6m
|
CAGR 3-Years
2%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
![]() |
Inter Parfums Inc
NASDAQ:IPAR
|
Common Stock
$32k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
![]() |
elf Beauty Inc
NYSE:ELF
|
Common Stock
$563k
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
Medifast Inc
Glance View
Medifast, Inc. engages in the provision of healthy living products and programs. The company is headquartered in Owings Mills, Maryland and currently employs 984 full-time employees. The firm's operations are conducted through its subsidiaries Jason Pharmaceuticals, Inc., OPTAVIA, LLC, Jason Enterprises, Inc., Jason Properties, LLC, Medifast Franchise Systems, Inc., Seven Crondall Associates, LLC, Corporate Events, Inc., OPTAVIA (Hong Kong) Limited, OPTAVIA (Singapore) PTE. LTD and OPTAVIA Health Consultation (Shanghai) Co., Ltd. The firm's product line includes approximately 137 consumable options, including, bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company, through Medifast Direct, its direct-to-consumer business unit.

See Also
What is Medifast Inc's Common Stock?
Common Stock
11k
USD
Based on the financial report for Dec 31, 2024, Medifast Inc's Common Stock amounts to 11k USD.
What is Medifast Inc's Common Stock growth rate?
Common Stock CAGR 1Y
0%
Over the last year, the Common Stock growth was 0%.